Research Institute of the MUHC/McGill University study proves that muscle atrophy in cystic fibrosis patients is genetic in origin.

At News Channel 12′s 32nd annual Cystic Fibrosis Telethon on Aug. 8, expect to see hosts dressed in ball gowns and tuxedos, dancers in elaborate costumes and musicians blaring music in the Fellowship Hall of First Baptist Church in downtown New Bern.

Celebrate summer with a gourmet dinner made by a local chef from fresh, locally grown produce.

Need some dishes for your kitchen? How about a new outfit for the weekend? Or maybe a George Bush doll that passes gas? You can find those things and thousands of others at the Three Day Stampede in Bristol.

Join us this Saturday July 25th for the second installment of “The Cystic Fibrosis Foundation’s Jam on Walnut 2009″ Act two brings to the stage national recording act The ‘Gin Blossoms.’ Only $2.00 for a wristband.

In 1989 scientists identified the gene mutation that causes cystic fibrosis , which led to the hope that CF lung disease could be ‘cured’ using gene therapy.

Scientists have worked for 20 years to perfect gene therapy for the treatment of cystic fibrosis, which causes the body to produce dehydrated, thicker-than-normal mucus that clogs the lungs and leads to life threatening infections.

Since 1993, Syosset High Schoola s student government has been gathering for two nights during the school year to continue the search for a cure for cystic fibrosis .

Originally posted in Cystic Fibrosis News From Medical News Today

Cystic fibrosis medicines that help to break down mucus in the lungs may carry an unexpected long-term benefit, a study suggests. The treatments not only help breathing in the short term – they may also make lung infections develop to be less harmful in the long run, research from the University of Edinburgh shows. Scientists studied how bacteria which infect the lungs of cystic fibrosis patients gather nutrients from their surroundings.

Originally posted in Cystic Fibrosis News From Medical News Today

An innovative treatment for infections of the respiratory tract in cystic fibrosis patients has received a second orphan drug designation in the US only weeks after a first designation was granted. The recent designation relates to Burkholderia cepacia pathogens that can cause lethal infections in cystic fibrosis patients.

International Summer Burgerfest for a Cure 2009 WHEN: The next four weekends. WHERE: Damian’s on the River, 737 River Road, New Boston.

Fighting disease. President and CEO of Siemens Canada Limited, Roland Aurich, left, presents a symbolic cheque for $100,000 to representatives of the Canadian Cystic Fibrosis Foundation Ron Anderson, president of the Toronto Chapter, Julie Cookson, chief operating officer and Christine McCarthy, executive director of the Toronto Chapter.

Do you enjoy scaring people? Maybe you have put on a mask and hid behind a door waiting for a friend to walk in the room so you could make them jump.

Dr. MILES WEINBERGER is a professor of pediatrics at University of Iowa Hospital.

Originally posted in Cystic Fibrosis News From Medical News Today

Osmetech plc (LSE:OMH), the fast growing international molecular diagnostics company announces that it has received US Food & Drug Administration (‘FDA’) 510(k) clearance for its eSensor® Cystic Fibrosis Genotyping Test for use on the eSensor® XT-8 System.

Folks will be out walking Saturday morning for children with cystic fibrosis. Living with the disease is a daily struggle for one Marysville family.

The Cystic Fibrosis Foundation commends the nomination by President Obama of Francis Collins, M.D., Ph.D., as the new director of the National Institutes of Health .

Proceeds to benefit Cystic Fibrosis Foundation Robert Kinsella was the principal of Minoa Elementary School from 1966 to 1984.

Originally posted in Cystic Fibrosis News From Medical News Today

The Cystic Fibrosis Foundation announced today that all 50 states, plus the District of Columbia, have passed legislation requiring that all newborns be screened for cystic fibrosis (CF) by the year 2010. Early diagnosis of cystic fibrosis, a life-threatening, genetic disease, can have a dramatic impact on the health of those born with the condition.

All Fifty States to Screen Newborns for Cystic Fibrosis by 2010 Posted by: philcrosby on Tuesday, July 7, 2009 The Cystic Fibrosis Foundation announced today that all 50 states plus the District of Columbia have passed legislation requiring that all newborns be screened for cystic fibrosis by the year 2010.

Over 3,500 New York Life Insurance Company employees and agents volunteered over 50,000 hours on over 200 community projects in eight countries at estimated value over $1 million.

Originally posted in Cystic Fibrosis News From Medical News Today

An otherwise effective treatment for cystic fibrosis places patients at a high risk of sensorineural hearing loss, according to new research published in the July edition of Otolaryngology-Head and Neck Surgery. Cystic fibrosis is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide).

A common antibacterial treatment for cystic fibrosis can cause sensorineural hearing loss, finds a new study.

Disease foundations that are taking an increasing role in capital formation for local biotechs are nervously watching as the stock market and private capital markets wreak havoc with the companies that may hold the key to their future cures.

Originally posted in Journal of Cystic Fibrosis

We were interested to read recently in the Journal of ‘cepacia syndrome’ being successfully treated by combined nebulised and intravenous (IV) therapy with both meropenem and tobramycin in a 31 year old woman with cystic fibrosis (CF) and an en-bloc liver–pancreas transplant . This reminded us of one of our current patients who survived the ‘cepacia syndrome’ following treatment with IV antibiotics, nebulised tobramycin and recombinant human deoxyribonuclease (rhDNase) and remains relatively well 8 years later.

Originally posted in Journal of Cystic Fibrosis

Abstract: Early diagnosis and treatment of the respiratory and gastrointestinal complications of cystic fibrosis (CF) have led to improved survival with many patients living beyond the fourth decade. Along with this increased life expectancy is the risk of further disease associated with the chronic manifestations of their condition. We report a patient with documented CF related liver disease for which he was under routine surveillance that presented with histologically proven hepatocellular carcinoma (HCC). It is important that physicians are aware of this association as increased vigilance may lead to earlier diagnosis and perhaps, a better outcome.

Originally posted in Journal of Cystic Fibrosis

Abstract: Many countries have introduced newborn screening for cystic fibrosis to facilitate diagnosis prior to the development of lung disease. Although most infants with cystic fibrosis are asymptomatic from a respiratory point of view at diagnosis, structural lung disease has been detected by computed tomography. We present a case of an asymptomatic infant with cystic fibrosis diagnosed following newborn screening who had endobronchial infection with Pseudomonas aeruginosa and radiological evidence of bronchiectasis at 3 months of age.

Originally posted in Journal of Cystic Fibrosis

Abstract: Cystic fibrosis (CF; MIM# 219700) is the most frequent recessive disease in Caucasian patients. However, immigration from the Middle East and Africa to Europe is revealing different CFTR mutations.Here, we have described an 875+1G?A mutation, found for the first time in a homozygous state in an 8 yr old boy. He was the child of a couple of Egyptian first level cousins, both carriers of the mutation.The functional test revealed the 875+1G?A to be a severe mutation, leading to defective protein function as detected by nasal potential difference (NPD) measurements.

Originally posted in Journal of Cystic Fibrosis

Abstract: Mutation epidemiology in each ethnic group is important for cystic fibrosis diagnosis and genetic counselling. To date, little has been reported on the prevalence of cystic fibrosis in the Ecuadorian population where the mutation distribution appears to differ from that of Europe. We present a series of four Ecuadorian patients homozygous for the H609R mutation in the CFTR gene. This is the first report of detection of this mutation in the Ecuadorian population. Taking advantage of the homozygous status of the patients, an evaluation of the most important clinical parameters is presented. From the diagnostic point of view, the information provided by our study is of relevance in designing an appropriate strategy for genetic testing of patients in Ecuador and in European countries where immigration from Ecuador is common.